It is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS).... Jun 24
Bayer Zydus Pharma has been a successful partnership combining Bayer’s scientific expertise and commercialization of novel products backed by Cadila Healthcare’s strong India ... Jun 22
Brivaracetam is used to treat partial-onset of seizures (epilepsy)... Jun 14
Zydus, today announced that it has received permission to initiate the Phase 1 clinical trial of ZYIL1, a novel oral small molecule NLRP3 inhibitor candidate.... Dec 07
NLRP3 inflammasome inhibitor can selectively modulate the inflammatory responses caused by the ‘Cytokine Storm’ in Acute Respiratory Distress Syndrome... Nov 03
Albuterol is a bronchodilator and it helps open up the airways in your lungs to make it easier to breathe. ... Oct 23
Zydus Cadila has received final approval from the USFDA to market Solifenacin Succinate Tablets, in the strengths of 5 mg and 10 mg... Oct 21
Zydus Healthcare Limited announced that it is launching the anti-diabetic Dapagliflozin tablets in India upon its patent expiry under the brand name ‘Dapaglyn’... Oct 05
Zydus Cadila has received tentative approval from the USFDA to market Palbociclib Capsules, an anti-cancer medicine... Sep 24
-Advertisements-
Saturday, April 20, 2024
